Your session is about to expire
← Back to Search
Chemotherapy + Proton Therapy for Pancreatic Cancer
Study Summary
This trial is testing a new way to give proton therapy and chemotherapy for pancreatic cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You did not follow the doctor's instructions for the initial chemotherapy treatment.I have moderate to severe nerve pain or damage. I also have Gilbert's disease or a specific genetic condition.My diagnosis is pancreatic adenocarcinoma.I am not currently using, nor have I used in the last 14 days, any strong CYP3A4 inhibitors or inducers.I have not had chemotherapy, except for certain types.I haven't had radiation in the abdomen that would affect this study.I have not had surgery to remove pancreatic cancer.My scans show my tumor can't be surgically removed due to its location.I am HIV-positive and on antiretroviral therapy.My pancreatic cancer cannot be removed with surgery.Your kidneys are working well enough to filter out waste from your blood.Your total bilirubin level should be less than 2 mg/dL.Your platelet count is at least 100,000 per cubic millimeter.I am fully active or can carry out light work.You have enough infection-fighting white blood cells in your body.I have experienced severe side effects from initial chemotherapy.Your creatinine levels are within a certain range.My pancreatic cancer has not spread to distant areas.You have had to lower the dose of your chemotherapy more than two times.
- Group 1: Pancreatic Proton Therapy With Concurrent Gem + Nab-paclitaxel
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment to this clinical trial open to elderly individuals?
"This medical research seeks individuals aged 18 or older, but under the age of 75."
Is enrollment open for this clinical trial at present?
"According to clinicaltrials.gov, this medical investigation is currently seeking participants. The experiment was initially made public on April 2nd 2019 and further updated October 10th 2022."
How many participants are engaged with this experiment?
"Affirmative, the details on clinicaltrials.gov demonstrate that this experiment is currently recruiting volunteers. Initially posted on April 2nd 2019 and updated October 10th 2022, 24 individuals are being sought after from two separate medical facilities."
Have any other trials elucidated the efficacy of this remedy?
"This form of treatment first gained attention in 1997, as City of Hope Comprehensive Cancer Center began studying it. After over two decades of research, there are 1857 completed trials thus far and 1113 ongoing studies; a significant amount being hosted out of Baltimore, Maryland."
Who satisfies the eligibility criteria for this experiment?
"This trial has a specific set of requirements that must be met. These include having cancer of the pancreas and being between 18-75 years old. Aiming to recruit 24 individuals, this research is now accepting applications."
What afflictions are usually ameliorated by this therapy?
"This remedy is often prescribed for the treatment of cancer metastasis. Additionally, it may also be effective in treating localized non-small cell lung cancer, bladder cancer and malignancies that affect the urinary tract."
Share this study with friends
Copy Link
Messenger